191 related articles for article (PubMed ID: 16336208)
1. Chelation and determination of labile iron in primary hepatocytes by pyridinone fluorescent probes.
Ma Y; de Groot H; Liu Z; Hider RC; Petrat F
Biochem J; 2006 Apr; 395(1):49-55. PubMed ID: 16336208
[TBL] [Abstract][Full Text] [Related]
2. Determination of the chelatable iron pool of isolated rat hepatocytes by digital fluorescence microscopy using the fluorescent probe, phen green SK.
Petrat F; Rauen U; de Groot H
Hepatology; 1999 Apr; 29(4):1171-9. PubMed ID: 10094962
[TBL] [Abstract][Full Text] [Related]
3. Determination of the chelatable iron pool of single intact cells by laser scanning microscopy.
Petrat F; de Groot H; Rauen U
Arch Biochem Biophys; 2000 Apr; 376(1):74-81. PubMed ID: 10729192
[TBL] [Abstract][Full Text] [Related]
4. Determination of the labile iron pool of human lymphocytes using the fluorescent probe, CP655.
Ma Y; Liu Z; Hider RC; Petrat F
Anal Chem Insights; 2007 Sep; 2():61-7. PubMed ID: 19662178
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis and properties of novel iron(III)-specific fluorescent probes.
Luo W; Ma YM; Quinn PJ; Hider RC; Liu ZD
J Pharm Pharmacol; 2004 Apr; 56(4):529-36. PubMed ID: 15099448
[TBL] [Abstract][Full Text] [Related]
6. Selective determination of mitochondrial chelatable iron in viable cells with a new fluorescent sensor.
Petrat F; Weisheit D; Lensen M; de Groot H; Sustmann R; Rauen U
Biochem J; 2002 Feb; 362(Pt 1):137-47. PubMed ID: 11829750
[TBL] [Abstract][Full Text] [Related]
7. Assessment of chelatable mitochondrial iron by using mitochondrion-selective fluorescent iron indicators with different iron-binding affinities.
Rauen U; Springer A; Weisheit D; Petrat F; Korth HG; de Groot H; Sustmann R
Chembiochem; 2007 Feb; 8(3):341-52. PubMed ID: 17219451
[TBL] [Abstract][Full Text] [Related]
8. Effects of deferasirox and deferiprone on cellular iron load in the human hepatoma cell line HepaRG.
Gaboriau F; Leray AM; Ropert M; Gouffier L; Cannie I; Troadec MB; Loréal O; Brissot P; Lescoat G
Biometals; 2010 Apr; 23(2):231-45. PubMed ID: 19997770
[TBL] [Abstract][Full Text] [Related]
9. Characterization of two isomeric beta-d-glucosiduronic acids derived from 1,2-diethyl-3-hydroxypyridin-4-one (CP94) in rat liver homogenate incubates.
Liu DY; Liu ZD; Piyamongkol S; Lu SL; Hider RC
J Pharm Pharmacol; 2002 Jul; 54(7):951-7. PubMed ID: 12162714
[TBL] [Abstract][Full Text] [Related]
10. A fluorescence assay for assessing chelation of intracellular iron in a membrane model system and in mammalian cells.
Cabantchik ZI; Glickstein H; Milgram P; Breuer W
Anal Biochem; 1996 Jan; 233(2):221-7. PubMed ID: 8789722
[TBL] [Abstract][Full Text] [Related]
11. Iron mobilization, cytoprotection, and inhibition of cell proliferation in normal and transformed rat hepatocyte cultures by the hydroxypyridinone CP411, compared to CP20: a biological and physicochemical study.
Gaboriau F; Chantrel-Groussard K; Rakba N; Loyer P; Pasdeloup N; Hider RC; Brissot P; Lescoat G
Biochem Pharmacol; 2004 Apr; 67(8):1479-87. PubMed ID: 15041465
[TBL] [Abstract][Full Text] [Related]
12. Multidentate pyridinones inhibit the metabolism of nontransferrin-bound iron by hepatocytes and hepatoma cells.
Chua AC; Ingram HA; Raymond KN; Baker E
Eur J Biochem; 2003 Apr; 270(8):1689-98. PubMed ID: 12694182
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of iron toxicity in rat and human hepatocyte cultures by the hydroxypyridin-4-ones CP20 and CP94.
Chenoufi N; Hubert N; Loréal O; Morel I; Pasdeloup N; Cillard J; Brissot P; Lescoat G
J Hepatol; 1995 Aug; 23(2):166-73. PubMed ID: 7499788
[TBL] [Abstract][Full Text] [Related]
14. Chelation and mobilization of cellular iron by different classes of chelators.
Zanninelli G; Glickstein H; Breuer W; Milgram P; Brissot P; Hider RC; Konijn AM; Libman J; Shanzer A; Cabantchik ZI
Mol Pharmacol; 1997 May; 51(5):842-52. PubMed ID: 9145923
[TBL] [Abstract][Full Text] [Related]
15. Subcellular distribution of chelatable iron: a laser scanning microscopic study in isolated hepatocytes and liver endothelial cells.
Petrat F; de Groot H; Rauen U
Biochem J; 2001 May; 356(Pt 1):61-9. PubMed ID: 11336636
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis, physicochemical properties, and evaluation of novel iron chelators with fluorescent sensors.
Ma Y; Luo W; Quinn PJ; Liu Z; Hider RC
J Med Chem; 2004 Dec; 47(25):6349-62. PubMed ID: 15566304
[TBL] [Abstract][Full Text] [Related]
17. HPLC determination of 1,2-diethyl-3-hydroxypyridin-4-one (CP94), its iron complex [Fe(III) (CP94)3] and glucuronide conjugate [CP94-GLUC] in serum and urine of thalassaemic patients.
Epemolu RO; Ackerman R; Porter JB; Hider RC; Damani LA; Singh S
J Pharm Biomed Anal; 1994 Jul; 12(7):923-30. PubMed ID: 7981322
[TBL] [Abstract][Full Text] [Related]
18. Iron-induced mitochondrial permeability transition in cultured hepatocytes.
Rauen U; Petrat F; Sustmann R; de Groot H
J Hepatol; 2004 Apr; 40(4):607-15. PubMed ID: 15030976
[TBL] [Abstract][Full Text] [Related]
19. Iron mobilization from hepatocyte monolayer cultures by chelators: the importance of membrane permeability and the iron-binding constant.
Porter JB; Gyparaki M; Burke LC; Huehns ER; Sarpong P; Saez V; Hider RC
Blood; 1988 Nov; 72(5):1497-503. PubMed ID: 3179437
[TBL] [Abstract][Full Text] [Related]
20. Rhodamine labeling of 3-hydroxy-4-pyridinone iron chelators is an important contribution to target Mycobacterium avium infection.
Moniz T; Nunes A; Silva AM; Queirós C; Ivanova G; Gomes MS; Rangel M
J Inorg Biochem; 2013 Apr; 121():156-66. PubMed ID: 23384853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
